VTx-002

· Vector Y Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VTx-002, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study is to Assess the Safety and Tolerability of VTx-002 in Participants With ALS [Phase 1, Phase 2]